{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT02682511",
            "orgStudyIdInfo": {
                "id": "CPI-IFE-004"
            },
            "organization": {
                "fullName": "Cumberland Pharmaceuticals",
                "class": "INDUSTRY"
            },
            "briefTitle": "Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension",
            "officialTitle": "A Phase 2 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Ifetroban in Patients With Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension (SSc-PAH)",
            "therapeuticArea": [
                "Dermatology",
                "Immunology and Rheumatology",
                "Other"
            ],
            "study": "oral-ifetroban-to-treat-diffuse-cutaneous-systemic-sclerosis-ssc-or-ssc-associated-pulmonary-arterial-hypertension"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2017-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2016-02-08",
            "studyFirstSubmitQcDate": "2016-02-10",
            "studyFirstPostDateStruct": {
                "date": "2016-02-15",
                "type": "ESTIMATED"
            },
            "lastUpdateSubmitDate": "2024-06-05",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-06",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Cumberland Pharmaceuticals",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this phase 2 multicenter, randomized, double-blind, placebo-controlled, study is to assess the safety and efficacy of ifetroban in patients with diffuse cutaneous systemic SSc (dcSSc) or SSc-associated pulmonary arterial hypertension (SSc-PAH).",
            "detailedDescription": "This study is a randomized, placebo-controlled, double-blind phase 2 trial of patients with dcSSc or SSc-PAH. Twenty participants with SSc-PAH and 14 participants with dcSSc will be randomized to receive either oral ifetroban daily or matching placebo. Study participants will be treated for 12 months, followed by a 30-day follow-up period. The study will test whether ifetroban is safe and statistically superior to placebo in reducing the effects of their disease at month 12 and explore the ability of ifetroban to prevent or reverse progression in patients with early disease duration and reverse established disease in patients with longer disease duration."
        },
        "conditionsModule": {
            "conditions": [
                "Scleroderma, Diffuse",
                "Scleroderma, Systemic",
                "Scleroderma, Limited",
                "Sclerosis, Progressive Systemic",
                "Skin Diseases",
                "Connective Tissue Diseases",
                "Pathologic Processes",
                "Autoimmune Diseases"
            ],
            "keywords": [
                "Ifetroban",
                "Scleroderma",
                "Systemic Sclerosis"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 34,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Patients with dcSSc",
                    "type": "EXPERIMENTAL",
                    "description": "Patients with dcSSc will be randomized to receive either oral ifetroban or oral placebo daily for 365 days",
                    "interventionNames": [
                        "Drug: Oral Ifetroban",
                        "Drug: Oral Placebo"
                    ]
                },
                {
                    "label": "Patients with SSc-PAH",
                    "type": "EXPERIMENTAL",
                    "description": "Patients with SSc-PAH will be randomized to receive either oral ifetroban or oral placebo daily for 365 days",
                    "interventionNames": [
                        "Drug: Oral Ifetroban",
                        "Drug: Oral Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Oral Ifetroban",
                    "description": "Subjects will be treated with oral ifetroban or placebo daily for 365 days",
                    "armGroupLabels": [
                        "Patients with SSc-PAH",
                        "Patients with dcSSc"
                    ],
                    "otherNames": [
                        "Ifetroban"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Oral Placebo",
                    "description": "Subjects will be treated with oral ifetroban or placebo daily for 365 days",
                    "armGroupLabels": [
                        "Patients with SSc-PAH",
                        "Patients with dcSSc"
                    ],
                    "otherNames": [
                        "Ifetroban"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Incidence of adverse events (AEs) and Serious AEs (SAEs)",
                    "description": "Safety is measured using AEs, including clinical significant changes in vital signs, laboratory test abnormalities and clinical tolerability of ifetroban.",
                    "timeFrame": "56 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change from baseline in forced vital capacity (FVC)",
                    "description": "To determine if ifetroban improves pulmonary function in subjects with diffuse cutaneous SSc or SSc-PAH compared to placebo as measured by a change from baseline FVC.",
                    "timeFrame": "Baseline, 12, 26, and 52 weeks"
                },
                {
                    "measure": "Change from baseline in diffusion capacity for carbon monoxide (DLCO)",
                    "description": "To determine if ifetroban improves pulmonary function in subjects with diffuse cutaneous SSc or SSc-PAH compared to placebo as measured by a change from baseline diffusion capacity for carbon monoxide (DLCO)",
                    "timeFrame": "Baseline, 12, 26, and 52 weeks"
                },
                {
                    "measure": "Change from baseline in the modified Rodnan skin score (mRSS)",
                    "description": "The efficacy of treatment on skin fibrosis will be measured by changes from baseline in mRSS, a measure of skin thickness, at 52 weeks.",
                    "timeFrame": "Baseline, 12, 26, 39, and 52 weeks"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Change from baseline in ventricular function as determined by cardiac MRI",
                    "timeFrame": "Baseline, 26, and 52 weeks"
                },
                {
                    "measure": "Change from baseline in ventricular function as determined by echocardiography",
                    "timeFrame": "Baseline, 26, and 52 weeks"
                },
                {
                    "measure": "Improve skin and peripheral vascular disease as measured by active digital ulcer count",
                    "timeFrame": "Baseline, 12, 26, 39, and 52 weeks"
                },
                {
                    "measure": "Improve skin and peripheral vascular disease as measured by the subject's self-assessment of pain in digits by a visual analog scale (VAS), if active digital ulcers are present.",
                    "timeFrame": "Baseline, 12, 26, 39, and 52 weeks"
                },
                {
                    "measure": "Change from baseline in blood biomarkers",
                    "timeFrame": "Baseline, 26, and 52 weeks"
                },
                {
                    "measure": "Change from baseline in skin biomarkers",
                    "timeFrame": "Baseline, 26, and 52 weeks"
                },
                {
                    "measure": "Change from baseline in erythrocyte sedimentation rate",
                    "timeFrame": "Baseline, 26, and 52 weeks"
                },
                {
                    "measure": "Change from baseline in subject-reported health status assessed by the Scleroderma Health Assessment Questionnaire (SHAQ)",
                    "timeFrame": "Baseline, 12, 26, 39, and 52 weeks"
                },
                {
                    "measure": "Change from baseline in subject health and disability measurements as assessed by the World Health Organization Disability Assessment Assessment Schedule 2.0 (WHODAS 2.0)",
                    "timeFrame": "Baseline, 12, 26, 39, and 52 weeks"
                },
                {
                    "measure": "Change from baseline in subject-reported gastro-intestinal tract symptoms as assessed by the University of California, Los Angles (UCLA) Scleroderma Clinical Trial Consortium (SCTC) Gastrointestinal Tract (GIT) Questionnaire",
                    "timeFrame": "Baseline, 12, 26, 39, and 52 weeks"
                },
                {
                    "measure": "Change from baseline in subject-reported outcomes as assessed by the short-form health survey (SF-36)",
                    "timeFrame": "Baseline, 12, 26, 39, and 52 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\nDiffuse Cutaneous Criterion:\n\n1. Systematic Sclerosis (SSc), as defined using the 2013 American College of Rheumatology/ European Union League Against Rheumatism Classification Criteria and dcSSc within 7 years following initial diagnosis as defined by the onset of the first non-Raynaud symptom.\n\nSSc-PAH Criteria:\n\n1. Adults fulfilling the 2013 American College of Rheumatology/ European Union League Against Rheumatism Classification Criteria with confirmed SSc-PAH (limited or dcSSc) confirmed via previous cardiac catheterization\n2. Stable oral therapy for PAH for at least 30 days (monotherapy or combination)\n3. New York Heart Association (NYHA) Class I-III Heart Failure\n\nExclusion Criteria:\n\n1. Have a diagnosis of systemic sclerosis sine scleroderma;\n2. Be less than 18 years of age or greater than or equal to 80 years of age;\n3. Be pregnant, nursing, or planning to become pregnant;\n4. Current or planned treatment with prostanoid therapy;\n5. Current or planned treatment with pirfenidone;\n6. Use of rituximab in the last 3 months;\n7. Use of mycophenolic acid (Myfortic, CellCept) at a stable dose for less than 3 months;\n8. Current or planned corticosteroid therapy greater than 15mg per day of prednisone or prednisone equivalent;\n9. Significant lung disease, defined as FVC \\< 50% predicted or DLCO \\<40% predicted;\n10. Significant kidney disease, defined as Glomerular Filtration Rate (GFR) \\< 60 ml/min;\n11. Have moderate or severe hepatic impairment;\n12. Contraindication to MRI (e.g., implanted magnetic material, claustrophobia);\n13. Known hypersensitivity to gadolinium;\n14. Any cause of pulmonary hypertension other than World Health Organization (WHO) Group I associated with SSc;\n15. Use of aspirin \\> 81 mg per day in the last two weeks;\n16. Use of warfarin, heparin or other anticoagulants in the last 30 days;\n17. Recent (within 6 weeks) myocardial infarction or persistent atrial arrhythmias;\n18. Have a history of allergy or hypersensitivity to ifetroban;\n19. Have taken investigational drugs within 30 days before study treatment administration;\n20. Inability to understand the requirements of the study, inability to understand spoken English and abide by the study restrictions and to return for the required treatments and assessments;\n21. Be otherwise unsuitable for the study, in the opinion of the investigator.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "80 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Ingrid Anderson, PhD, CCRP",
                    "role": "CONTACT",
                    "phone": "615-255-0068",
                    "phoneExt": "250",
                    "email": "ianderson@cumberlandpharma.com"
                },
                {
                    "name": "Ines Macias-Perez, PhD",
                    "role": "CONTACT",
                    "phone": "615-564-2188",
                    "email": "imaciasperez@cumberlandpharma.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Evan Brittain, MD",
                    "affiliation": "Vanderbilt University Medical Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "The Universtity of Arizona Arthrtis Center",
                    "status": "RECRUITING",
                    "city": "Tucson",
                    "state": "Arizona",
                    "zip": "85724",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jazmin Dagnino",
                            "role": "CONTACT",
                            "email": "jazmindagnino@arizona.edu"
                        },
                        {
                            "name": "Jawad Bilal, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.22174,
                        "lon": -110.92648
                    }
                },
                {
                    "facility": "UCLA",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90095-1670",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Nashla Barroso",
                            "role": "CONTACT",
                            "phone": "310-825-9682"
                        },
                        {
                            "name": "Suzanne Kafaja, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "New Life Medical Research Center, Inc.",
                    "status": "WITHDRAWN",
                    "city": "Hialeah",
                    "state": "Florida",
                    "zip": "33012",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 25.8576,
                        "lon": -80.27811
                    }
                },
                {
                    "facility": "Cleveland Clinic - Florida",
                    "status": "RECRUITING",
                    "city": "Weston",
                    "state": "Florida",
                    "zip": "33331",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Marie Briceno, MD",
                            "role": "CONTACT",
                            "email": "BRICENM@ccf.org"
                        },
                        {
                            "name": "Lilian Cadet",
                            "role": "CONTACT",
                            "email": "CADETL@ccf.org"
                        },
                        {
                            "name": "Franck Rahaghi, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 26.10037,
                        "lon": -80.39977
                    }
                },
                {
                    "facility": "Johns Hopkins University",
                    "status": "RECRUITING",
                    "city": "Baltimore",
                    "state": "Maryland",
                    "zip": "21224",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Gwen Leatherman, RN, MS, CCRP",
                            "role": "CONTACT",
                            "phone": "410-550-8582"
                        },
                        {
                            "name": "Laura Hummer, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.29038,
                        "lon": -76.61219
                    }
                },
                {
                    "facility": "Massachusetts General Hospital",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02114",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ana Frenandez",
                            "role": "CONTACT",
                            "phone": "617-724-2792"
                        },
                        {
                            "name": "Flavia Castelino, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Boston University School of Medicine",
                    "status": "WITHDRAWN",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02118",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "University of Nebraska Medical Center",
                    "status": "RECRUITING",
                    "city": "Omaha",
                    "state": "Nebraska",
                    "zip": "68198",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Tony Brandner, MPH",
                            "role": "CONTACT",
                            "phone": "402-559-4797",
                            "email": "tony.brandner@unmc.edu"
                        },
                        {
                            "name": "Tammy Wichman, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.25626,
                        "lon": -95.94043
                    }
                },
                {
                    "facility": "Hospital for Special Surgery",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10021",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Beemnet Amdemicael",
                            "role": "CONTACT",
                            "phone": "212-774-2123"
                        },
                        {
                            "name": "Jessica Gordon, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Thomas Jefferson University",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19107",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Marsha Simmons",
                            "role": "CONTACT",
                            "email": "Marsha.Simmons@jefferson.edu"
                        },
                        {
                            "name": "Fabian A Mendoza-Ballesteros, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "Medical University of South Carolina",
                    "status": "TERMINATED",
                    "city": "Charleston",
                    "state": "South Carolina",
                    "zip": "29403",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.77657,
                        "lon": -79.93092
                    }
                },
                {
                    "facility": "Vanderbilt University Medical Center",
                    "status": "WITHDRAWN",
                    "city": "Nashville",
                    "state": "Tennessee",
                    "zip": "37203",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.16589,
                        "lon": -86.78444
                    }
                },
                {
                    "facility": "Baylor Research Institute",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75204-651",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Susan",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Susan Mathai, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                },
                {
                    "facility": "Benaraoya Research Institute at Virginia Mason",
                    "status": "WITHDRAWN",
                    "city": "Seattle",
                    "state": "Washington",
                    "zip": "98101",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 47.60621,
                        "lon": -122.33207
                    }
                },
                {
                    "facility": "KDH - Kokilaben Dhirubhai Ambani Hospital",
                    "status": "RECRUITING",
                    "city": "Mumbai",
                    "state": "Maharashtra",
                    "zip": "400053",
                    "country": "India",
                    "contacts": [
                        {
                            "name": "Gauri Pandit, MBBS",
                            "role": "CONTACT",
                            "email": "Gauri.Pandit@relianceada.com"
                        },
                        {
                            "name": "Sanchita Gupte, MBBS",
                            "role": "CONTACT",
                            "email": "sanchita.gupte@relianceada.com"
                        },
                        {
                            "name": "Sunil Singh, MBBS",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 19.07283,
                        "lon": 72.88261
                    }
                },
                {
                    "facility": "B. J. Government Medical College",
                    "status": "RECRUITING",
                    "city": "Pune",
                    "state": "Maharashtra",
                    "zip": "411001",
                    "country": "India",
                    "contacts": [
                        {
                            "name": "Vijaya Chavan",
                            "role": "CONTACT",
                            "email": "orion.vijayachavan@gmail.com"
                        },
                        {
                            "name": "Arohi Metkar",
                            "role": "CONTACT",
                            "email": "Orion.arohi@gmail.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 18.51957,
                        "lon": 73.85535
                    }
                },
                {
                    "facility": "PGIMER",
                    "status": "RECRUITING",
                    "city": "Chandigarh",
                    "zip": "160012",
                    "country": "India",
                    "contacts": [
                        {
                            "name": "Shefali Khanna, MD",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Shashank Gaur",
                            "role": "CONTACT",
                            "email": "ethicscare@ecrsindia.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 30.73629,
                        "lon": 76.7884
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000081029",
                    "term": "Pulmonary Arterial Hypertension"
                },
                {
                    "id": "D000012595",
                    "term": "Scleroderma, Systemic"
                },
                {
                    "id": "D000045743",
                    "term": "Scleroderma, Diffuse"
                },
                {
                    "id": "D000012594",
                    "term": "Scleroderma, Localized"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                },
                {
                    "id": "D000003240",
                    "term": "Connective Tissue Diseases"
                },
                {
                    "id": "D000045745",
                    "term": "Scleroderma, Limited"
                },
                {
                    "id": "D000001327",
                    "term": "Autoimmune Diseases"
                },
                {
                    "id": "D000012598",
                    "term": "Sclerosis"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "ancestors": [
                {
                    "id": "D000006976",
                    "term": "Hypertension, Pulmonary"
                },
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M2261",
                    "name": "Pulmonary Arterial Hypertension",
                    "asFound": "Pulmonary Arterial Hypertension",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10024",
                    "name": "Hypertension",
                    "relevance": "LOW"
                },
                {
                    "id": "M15415",
                    "name": "Sclerosis",
                    "asFound": "Sclerosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "asFound": "Skin Diseases",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4629",
                    "name": "Autoimmune Diseases",
                    "asFound": "Autoimmune Diseases",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15412",
                    "name": "Scleroderma, Systemic",
                    "asFound": "Scleroderma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M25560",
                    "name": "Scleroderma, Diffuse",
                    "asFound": "Scleroderma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6464",
                    "name": "Connective Tissue Diseases",
                    "asFound": "Connective Tissue Diseases",
                    "relevance": "HIGH"
                },
                {
                    "id": "M25562",
                    "name": "Scleroderma, Limited",
                    "asFound": "Scleroderma, Limited",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15411",
                    "name": "Scleroderma, Localized",
                    "asFound": "Scleroderma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10027",
                    "name": "Hypertension, Pulmonary",
                    "relevance": "LOW"
                },
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T4807",
                    "name": "Pulmonary Arterial Hypertension",
                    "asFound": "Pulmonary Arterial Hypertension",
                    "relevance": "HIGH"
                },
                {
                    "id": "T5565",
                    "name": "Systemic Scleroderma",
                    "asFound": "Scleroderma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T1861",
                    "name": "Diffuse Cutaneous Systemic Sclerosis",
                    "asFound": "Diffuse Cutaneous Systemic Sclerosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3490",
                    "name": "Localized Scleroderma",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000078904",
                    "term": "Ifetroban"
                }
            ],
            "ancestors": [
                {
                    "id": "D000010975",
                    "term": "Platelet Aggregation Inhibitors"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M228666",
                    "name": "Ifetroban",
                    "asFound": "Sacrococcygeal",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13865",
                    "name": "Platelet Aggregation Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "PlAggInh",
                    "name": "Platelet Aggregation Inhibitors"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}